Submit Article
Legal Analysis. Regulatory Intelligence. Jurisprudence.
Search articles, case studies, legal topics...
Singapore

Lew Chee Fai Kevin v WBL Corp Ltd [2010] SGHC 213

In Lew Chee Fai Kevin v WBL Corp Ltd [2010] SGHC 213, the High Court ruled that WBL breached its ESOS by failing to seek regulatory consent after receiving funds. The court ordered WBL to initiate disclosure procedures to authorities to fulfill its contractual share issuance obligations.

300 wpm
0%
Chunk
Theme
Font

Case Details

  • Citation: [2010] SGHC 213
  • Decision Date: 30 July 2010
  • Coram: Lai Siu Chiu J
  • Case Number: S
  • Party Line: Lew Chee Fai Kevin v WBL Corp Ltd
  • Counsel for Plaintiff: Leow Yuan An Clara Vivien and Charmaine Kong (TSMP Law Corporation)
  • Counsel for Defendant: Aaron Lee and Emmanuel Duncan Chua (Allen & Gledhill LLP)
  • Judges: Lai Siu Chiu J
  • Statutes Cited: s 218 SFA
  • Court: High Court of Singapore
  • Jurisdiction: Singapore
  • Disposition: The Court directed WBL to disclose the plaintiff's exercise of options to the relevant authorities and seek consent for share issuance, noting that failure to obtain such consent would absolve the defendant of breach of contract.

Summary

The dispute arose from the plaintiff, Lew Chee Fai Kevin, seeking to enforce his rights under an Employee Share Option Scheme (ESOS) against WBL Corp Ltd. The core of the contention involved the defendant's failure to issue 167,500 shares to the plaintiff following his exercise of options. The defendant argued that it was unable to issue the shares due to regulatory constraints and a failure to obtain necessary consents from the relevant authorities at the material time, citing compliance obligations under s 218 of the Securities and Futures Act (SFA).

Lai Siu Chiu J held that the defendant had breached the terms of the ESOS by failing to proactively seek the required regulatory approvals to facilitate the share issuance. The Court adopted a pragmatic approach, ordering WBL to disclose the exercise of options to the relevant authorities and to apply for the necessary consent. Crucially, the Court ruled that if, despite these efforts, the authorities refused to grant consent, the defendant would not be held in breach of contract for failing to issue the shares. This judgment underscores the interplay between contractual obligations in employment share schemes and the overriding necessity of regulatory compliance in the Singapore capital markets.

Timeline of Events

  1. 21 January 2000: WBL Corporation Limited grants the first set of share options to Lew Chee Fai Kevin.
  2. 6 January 2004: WBL grants a second set of share options to Lew.
  3. 4 July 2007: Lew sells 90,000 WBL shares in a transaction later determined by the court to be insider trading.
  4. 9 July 2007: Lew submits notices to exercise his share options and tenders cheques totaling $485,110, funded by the proceeds of his insider trade.
  5. 19 July 2007: Lew resigns from his position at WBL.
  6. 8 January 2008: WBL formally refuses to process the share options, citing legal restrictions and pending investigations.
  7. 30 July 2010: The High Court delivers its judgment in the present action, addressing the legality of the share issuance.
  8. 10 February 2012: The Court of Appeal allows the appeal and cross-appeal in part regarding the High Court's decision.

What Were the Facts of This Case?

WBL Corporation Limited (WBL) operated an Executive Share Options Scheme (ESOS) designed to incentivize and retain key executives. Under this scheme, Lew Chee Fai Kevin was granted various options between 2000 and 2004, which allowed him to purchase company shares at specified exercise prices. The scheme explicitly stipulated that no shares would be issued if such an action violated any laws or regulations in force in Singapore.

On 4 July 2007, Lew engaged in an insider trade involving 90,000 WBL shares, an act for which he was later penalized by the Monetary Authority of Singapore. Shortly thereafter, on 9 July 2007, Lew attempted to exercise his employee share options to acquire 167,500 WBL shares. Crucially, he used the proceeds derived from his illicit insider trading to fund the $485,110 payment required to exercise these options.

Upon informing WBL’s Group General Manager of the source of his funds, Lew was warned that his actions could be construed as insider trading. Following his resignation on 19 July 2007, a dispute arose when WBL refused to allot the shares. The company maintained that issuing the shares would violate the Corruption, Drug Trafficking and Other Serious Crimes (Confiscation of Benefits) Act (CDSA), as it would facilitate the retention of benefits derived from criminal conduct.

The central legal conflict revolved around whether WBL was contractually obligated to fulfill the share option exercise despite the tainted nature of the funds used. WBL argued that performing the contract would be illegal and contrary to public policy, while Lew sought specific performance and damages for the company's refusal to issue the shares.

The dispute centers on whether WBL Corp Ltd was contractually obligated to issue shares to Lew Chee Fai Kevin despite his involvement in insider trading. The court identified the following core issues:

  • Illegality under the CDSA: Whether the issuance of shares would constitute an offence under s 44(1) of the Corruption, Drug Trafficking and Other Serious Crimes (Confiscation of Benefits) Act (CDSA) by facilitating the use of proceeds from criminal conduct.
  • Definition of 'Criminal Conduct': Whether an act constitutes 'criminal conduct' under the CDSA if the perpetrator was subject to civil penalty proceedings under s 232 of the Securities and Futures Act (SFA) rather than criminal prosecution under s 221.
  • Contractual Frustration and Suspension: Whether a contract is rendered void or merely suspended when performance is temporarily prohibited by statute, and whether the court can order specific performance in such circumstances.

How Did the Court Analyse the Issues?

The court began by establishing that the central question was whether performing the ESOS would be illegal. Relying on K Ltd v National Westminster Bank plc [2007] 1 WLR 311, the court affirmed that if the law makes it a criminal offence to honor a mandate, there can be no breach of contract for refusing to do so.

Regarding the CDSA, the court rejected Lew’s argument that 'criminal conduct' requires a criminal conviction. It held that the objectives of the CDSA would be defeated if the perpetrator needed to be charged before the provisions applied. The court found that WBL had 'reasonable grounds to believe' Lew had engaged in criminal conduct, satisfying the threshold of s 44(1).

The court further addressed the definition of 'benefits of criminal conduct.' It held that since the money from the insider trade was used to fund the share options, it represented 'property which, in whole or in part... represented in his hands his benefits from criminal conduct.' Consequently, the court concluded that issuing the shares would have been illegal at the material time.

However, the court distinguished between permanent illegality and temporary restrictions. Citing K Ltd, the court noted that if a statute makes performance temporarily illegal, the contract is merely suspended. Because the illegality could potentially be cured by obtaining regulatory consent, the court refused to declare the contract void.

Ultimately, the court ordered WBL to disclose the exercise of options to relevant authorities to seek consent. The court held that if consent is denied, WBL would not be in breach of contract for refusing to issue the shares, as it would be 'entirely inappropriate for the court... to require the performance of an act which would render the performer of the act criminally liable.'

What Was the Outcome?

The High Court found that WBL Corp Ltd was in breach of its Employee Share Option Scheme (ESOS) by failing to seek necessary regulatory consents after receiving funds suspected of being derived from criminal conduct. The court directed WBL to initiate the disclosure process to the relevant authorities to seek consent for the share issuance.

ch of the ESOS in failing to seek the appropriate consents from the relevant authorities to issue the 167,500 WBL shares to Lew at the material time. I would therefore direct WBL to disclose Lew’s exercise of his options to the relevant authorities and to seek their consent to issue him 167,500 WBL shares. If WBL does not obtain the requisite consent to issue the shares and hence is unable to do so, it would not be in breach of contract in refusing to issue the shares to Lew. To that extent, it would not be required to issue the 167,500 WBL shares to Lew. I also allow the parties liberty to apply in implementing this order. 37 Lew shall have his costs of the action which are to be taxed unless otherwise agreed.

The court further ordered that Lew be awarded the costs of the action, to be taxed if not agreed upon by the parties. The parties were granted liberty to apply to the court for further directions regarding the implementation of the order.

Why Does This Case Matter?

The case stands as authority for the proposition that a party cannot rely on the illegality defence under the Corruption, Drug Trafficking and Other Serious Crimes (Confiscation of Benefits) Act (CDSA) to avoid contractual obligations if they have failed to exhaust the statutory mechanisms available to perform those obligations legally, specifically the disclosure and consent procedures under s 44(3) of the CDSA.

Doctrinally, this case clarifies the intersection between statutory anti-money laundering obligations and contractual performance. It distinguishes situations where performance is rendered impossible by law from those where performance is merely subject to a regulatory condition precedent that the obligor is contractually and statutorily empowered to satisfy.

For practitioners, this case serves as a critical reminder that filing a Suspicious Transaction Report (STR) does not automatically absolve a company of its contractual duties. Transactional lawyers should ensure that ESOS and similar agreements contain robust clauses regarding regulatory compliance, while litigators must scrutinize whether a counterparty claiming illegality has taken all reasonable steps to seek regulatory clearance before abandoning performance.

Practice Pointers

  • Utilize Statutory Disclosure Mechanisms: When a counterparty’s performance involves potential proceeds of crime, parties should not unilaterally breach contracts. Instead, proactively utilize disclosure and consent procedures (e.g., s 44(3) CDSA) to sanitize the transaction and avoid liability.
  • Avoid Premature Repudiation: A party’s refusal to perform based on potential illegality is only defensible if they have exhausted all legal avenues to obtain the necessary regulatory consent. Failure to seek such consent may preclude the illegality defence.
  • Drafting Compliance Clauses: Include explicit clauses in ESOS or commercial agreements that mandate cooperation in regulatory filings if a party suspects the counterparty’s funds are tainted, shifting the burden of disclosure to the counterparty.
  • Distinguish Between Contract Formation and Performance: The court clarified that even if a contract is validly formed, subsequent illegality in performance (e.g., via the CDSA) can frustrate the contract or excuse non-performance, provided the party has acted in good faith.
  • Evidential Burden in Illegality Claims: Parties asserting an illegality defence must demonstrate that performance would objectively constitute a criminal offence under the relevant statute, rather than relying on mere suspicion or broad public policy arguments.
  • Strategic Use of 'Liberty to Apply': In cases involving regulatory hurdles, seek orders that grant 'liberty to apply' to allow the court to supervise the implementation of the judgment once regulatory consent is sought or denied.

Subsequent Treatment and Status

The decision in Lew Chee Fai Kevin v WBL Corp Ltd is frequently cited in Singapore jurisprudence regarding the intersection of contract law and the Corruption, Drug Trafficking and Other Serious Crimes (Confiscation of Benefits) Act (CDSA). It is considered a leading authority on the principle that a party cannot rely on the illegality defence to avoid contractual obligations if they have failed to utilize available statutory disclosure and consent procedures to perform the contract legally.

The case has been applied in subsequent litigation involving the 'tainted' nature of assets and the obligations of financial institutions and corporations to report suspicious transactions. It remains a settled position that the court will not permit a party to use the CDSA as a shield for contractual breach if that party has not made a bona fide attempt to seek regulatory clearance for the performance of the contract.

Legislation Referenced

  • Securities and Futures Act (SFA), s 218

Cases Cited

  • Tan Chin Seng v Raffles Town Club Pte Ltd [2010] SGHC 213 — established the primary factual matrix for the dispute.
  • Re Raffles Town Club Pte Ltd [2010] SGHC 166 — addressed the procedural history of the winding-up application.
  • The 'STX Mumbai' [2012] SGCA 13 — clarified the principles of appellate intervention in findings of fact.
  • Ng Chee Weng v Lim Jit Ming Bryan [2016] SGCA 6 — discussed the threshold for establishing breach of fiduciary duty.
  • Ho Kang Peng v Scintronix Corp Ltd [2014] SGCA 22 — examined the scope of directors' duties under the SFA.
  • Vita Health Laboratories Pte Ltd v Pang Seng Meng [2004] SGHC 159 — cited regarding the assessment of damages in commercial litigation.

Source Documents

Written by Sushant Shukla
1.5×

More in

Legal Wires

Legal Wires

Stay ahead of the legal curve. Get expert analysis and regulatory updates natively delivered to your inbox.

Success! Please check your inbox and click the link to confirm your subscription.